Tenon Medical, Inc. Receives Nasdaq Delisting Warning

Tenon Medical, Inc. has received a notice from Nasdaq indicating non-compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market. The company reported stockholders' equity of $1,895,000 as of March 31, 2026, which is below the required $2,500,000. Tenon Medical has 45 days to submit a plan to regain compliance, with a potential extension of up to 180 days if the plan is accepted. The company is evaluating options to regain compliance and intends to submit a plan to Nasdaq. Failure to regain compliance could lead to delisting, although the company may appeal such a decision. This notice does not currently affect the trading of the company's stock or its business operations.